Clinical Trials on Choroidal Effusions in Japan
Total 10 results
-
BayerRegeneron PharmaceuticalsCompletedChoroidal NeovascularizationJapan
-
NovartisCompletedSubfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)Japan
-
PfizerCompletedMacular DegenerationJapan
-
BayerRegeneron PharmaceuticalsCompletedMyopia, PathologicalJapan, Taiwan, Hong Kong, Korea, Republic of, Singapore
-
Nihon UniversityCompletedPolypoidal Choroidal VasculopathyJapan
-
Novartis PharmaceuticalsCompletedPathological MyopiaGermany, India, Japan, Turkey, Austria, Switzerland, Italy, Lithuania, Hungary, France, Slovakia, United Kingdom, Korea, Republic of, Portugal, Hong Kong, Canada, Singapore, Spain, Latvia, Poland
-
Assiut UniversityUnknown
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompletedMalignant Pericardial EffusionJapan
-
Novartis PharmaceuticalsCompletedAge-related Macular Degeneration | Polypoidal Choroidal VasculopathyJapan, Taiwan, Hong Kong, Singapore, Thailand, Korea, Republic of, Malaysia
-
Taiho Oncology, Inc.RecruitingAdvanced Cholangiocarcinoma | FGFR2 Fusions | Gene RearrangementUnited States, Korea, Republic of, Spain, Japan, Portugal, Italy, China, Argentina, Brazil, Poland, Australia